EP1866333A4 - HUMAN CANCER SUPPRESSIVE GEN, DAVON CODED PROTEIN - Google Patents

HUMAN CANCER SUPPRESSIVE GEN, DAVON CODED PROTEIN

Info

Publication number
EP1866333A4
EP1866333A4 EP06732747A EP06732747A EP1866333A4 EP 1866333 A4 EP1866333 A4 EP 1866333A4 EP 06732747 A EP06732747 A EP 06732747A EP 06732747 A EP06732747 A EP 06732747A EP 1866333 A4 EP1866333 A4 EP 1866333A4
Authority
EP
European Patent Office
Prior art keywords
protein encoded
human cancer
suppressor gene
cancer suppressor
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06732747A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1866333A1 (en
Inventor
Jin-Woo Kim
Hyun-Kee Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1866333A1 publication Critical patent/EP1866333A1/en
Publication of EP1866333A4 publication Critical patent/EP1866333A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Developmental Disabilities (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Physics & Mathematics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Educational Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP06732747A 2005-03-30 2006-03-30 HUMAN CANCER SUPPRESSIVE GEN, DAVON CODED PROTEIN Withdrawn EP1866333A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020050026254A KR100689276B1 (ko) 2005-03-30 2005-03-30 인간 암 억제 유전자, 이에 의해 코딩되는 단백질
PCT/KR2006/001174 WO2006109941A1 (en) 2005-03-30 2006-03-30 Human cancer suppressor gene, protein encoded therein

Publications (2)

Publication Number Publication Date
EP1866333A1 EP1866333A1 (en) 2007-12-19
EP1866333A4 true EP1866333A4 (en) 2009-03-25

Family

ID=37087194

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06732747A Withdrawn EP1866333A4 (en) 2005-03-30 2006-03-30 HUMAN CANCER SUPPRESSIVE GEN, DAVON CODED PROTEIN

Country Status (6)

Country Link
EP (1) EP1866333A4 (zh)
JP (1) JP2008534006A (zh)
KR (1) KR100689276B1 (zh)
CN (1) CN101184774A (zh)
CA (1) CA2602976A1 (zh)
WO (1) WO2006109941A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110067107A (ko) * 2008-08-28 2011-06-21 온코세라피 사이언스 가부시키가이샤 종양 마커 및 암에 대한 치료적 표적으로서 ｔｂｃ１ｄ７
CN109251937B (zh) * 2018-09-05 2021-11-23 南京医科大学 一种人-Sin3相关多肽P18过表达质粒的构建方法及其应用
CN112480236B (zh) * 2020-12-16 2022-03-29 熊猫乳品集团股份有限公司 一种生物活性肽lecvepncrskr及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127178A (en) * 1998-03-20 2000-10-03 The Regents Of The University Of California Apoptotic peptides
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127178A (en) * 1998-03-20 2000-10-03 The Regents Of The University Of California Apoptotic peptides
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EPO Proteins [online] 22 March 2005 (2005-03-22), "Sequence 386 from Patent WO2005019258.", XP002472662, retrieved from EBI accession no. EPOP:CS039832 Database accession no. CS039832 *
DATABASE Geneseq [online] 19 February 2001 (2001-02-19), "Amino acid sequence of an active mimic of human Id2.", XP002472664, retrieved from EBI accession no. GSP:AAB19323 Database accession no. AAB19323 *
DATABASE JPO Proteins [online] 19 November 2003 (2003-11-19), "Human prostate cancer associated gene sequences and polypeptides.", XP002472665, retrieved from EBI accession no. JPOP:BD677008 Database accession no. BD677008 *
DATABASE UniProt [online] 1 February 1995 (1995-02-01), "DNA-binding protein inhibitor ID-2 (Inhibitor of DNA binding 2).", XP002472663, retrieved from EBI accession no. UNIPROT:Q02363 Database accession no. Q02363 *
DATABASE UniProt [online] 1 February 1995 (1995-02-01), "DNA-binding protein inhibitor ID-2 (Inhibitor of DNA binding 2).", XP002472666, retrieved from EBI accession no. UNIPROT:P41136 Database accession no. P41136 *
See also references of WO2006109941A1 *

Also Published As

Publication number Publication date
KR100689276B1 (ko) 2007-03-08
JP2008534006A (ja) 2008-08-28
CN101184774A (zh) 2008-05-21
EP1866333A1 (en) 2007-12-19
CA2602976A1 (en) 2006-10-19
WO2006109941A1 (en) 2006-10-19
KR20060104265A (ko) 2006-10-09

Similar Documents

Publication Publication Date Title
TWI365078B (en) Hemostat
EP1814544A4 (en) CANCER TREATMENTS
HK1205935A1 (zh) 非碎石性的腎結石療法
EP1871793A4 (en) PROTOONCOGEN HUMAN AND PROTEIN CODED THEREWITH
SG131104A1 (en) Protein microarray slide
EP1766073A4 (en) IMPROVING PROTEIN EXPRESSION
EP1830847A4 (en) CANCER TREATMENT
GB0514482D0 (en) Protein
GB0516068D0 (en) Well treatment
IL189377A0 (en) Combinations comprising dmxaa for the treatment of cancer
IL189376A0 (en) Combinations comprising dmxaa for the treatment of cancer
GB0428187D0 (en) Cancer treatment
GB0525394D0 (en) Body armour
IL190538A0 (en) Two-part code
EP1828237A4 (en) HUMAN CANCER SUPPRESSOR GENE, PROTEIN ENCODED THEREIN, EXPRESSION VECTOR CONTAINING THE GENE, AND CELL TRANSFORMED BY THE VECTOR
EP1866333A4 (en) HUMAN CANCER SUPPRESSIVE GEN, DAVON CODED PROTEIN
GB0413346D0 (en) Treating cancer
GB0502171D0 (en) Well treatment
GB0525535D0 (en) Tumour treatment
EP1838727A4 (en) HUMAN CANCER SUPPRESSION GENES, THE PROTEIN CODED THEREIN AND THE EXPRESSION VECTOR CONTAINING THEREOF
GB0507685D0 (en) Cancer treatment
GB0328690D0 (en) Tumour suppressor protein
GB0404675D0 (en) Cancer treatment
GB0505773D0 (en) Cancer treatment
GB0510770D0 (en) Cancer treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070927

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KIM, JIN-WOO

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KIM, HYUN-KEE

Inventor name: KIM, JIN-WOO

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090225

17Q First examination report despatched

Effective date: 20090526

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091206